Perrigo Company has announced that it has received final approval from the FDA to manufacture and market over-the-counter (OTC) Children’s Cetirizine Hydrochloride Oral Solution (Allergy) and Children’s Cetirizine Hydrochloride Oral Solution (Hives-Relief), 1mg/mL. The product will be marketed under store brand labels and is comparable to McNeil Consumer Healthcare’s Children’s Zyrtec(R) Oral Solution, 1mg/mL, indicated for indoor and outdoor allergy and hives relief. According to Wolters Kluwer data, brand sales for the original prescription strength version of the product for the last 12 months ending December 2007 were approximately $80 million. Perrigo’s Chairman and CEO Joseph C. Papa stated, “This approval reflects our strategy to be first to market with the important products that make quality healthcare more affordable for our customers.”The Company expects to begin shipping the product immediately.
